Benefits for children living with diabetesѰ
Benefits for people living with Type 2 diabetes
Try your free sensor today!
Which product is right for you?
FreeStyle Experiences
Read testimonials of real-life FreeStyle Libre users, their loved-ones
and healthcare professionals
Diabetes – No Longer Just a Side Dish In My Life
By Reepzy, diabetes tech advocate living with Type 1.
Type 1 Times 2
By Mary Murphy, an engineer, a person with Type 1 and a parent of a child with Type 1.
Thriving in the workplace
Real stories from the computing, tech and digital industry on how do you manage your diabetes?
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
Ѱ For children using FreeStyle Libre 2 or FreeStyle Libre 3 sensors aged 4-12, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre systems and interpreting its readings. For children using FreeStyle Libre 2 Plus sensors aged 2-12, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre systems and interpreting its readings.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
* FreeStyle Libre systems refers to the FreeStyle Libre 2 and FreeStyle Libre 3 systems. FreeStyle Libre apps refers to the FreeStyle LibreLink and FreeStyle Libre 3 apps.
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
◊◊ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
¤ Glucose readings are automatically displayed in the FreeStyle LibreLink app only when the smartphone and sensor are connected and in range.
^ Notifications will only be received when alarms are turned on and the sensor is within range of the reading device and unobstructed. You must have override do not disturb settings enabled to receive alarms and alerts on your smartphone.
‡ 60-minute warm-up required when applying the sensor.
₸ Sensor is water resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
§ The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
1. Leelarathna L. N Engl J Med. (2022). https:/doi:10.1056/NEJMoa2205650
2. Fokkert M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809
3. Haak, T., Diabetes Ther. (2017): https://doi.org/10.1007/s13300-016-0223-6
4. Park, S.H.; Yao, J.; Chua, X.H.; Chandran, S.R.; Gardner, D.S.L.; Khoo, C.M.; Müller-Riemenschneider, F.; Whitton, C.; van Dam, R.M. Diet and Physical Activity as Determinants of Continuously Measured Glucose Levels in Persons at High Risk of Type 2 Diabetes. Nutrients 2022, 14, 366. https://doi.org/10.3390/nu14020366
5. Edge, J. Arch Dis Child. (2017): https://doi.org/10.1136/archdischild-2016-311530
6. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142
7. Campbell, F. Pediatric Diabetes. (2018): https://doi.org/10.1111/pedi.12735
8. Data on file, Abbott Diabetes Care, Inc.
9. Scott, Eleanor M., et al. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes. Diabetes Technology & Therapeutics, 20.3 (2018):180-18
ADC-66200 v5.0